Skip to content
The GLP-1 Verdict
Menu
Ranked #26 · Grade B

Telos Rx review

By Alyssa Selinger, Editor

Carries one of the deepest published catalogs in the ranking — compounded semaglutide and tirzepatide plus needle-free oral and microdosed routes, PT-141, intranasal NAD+ and a wall of recovery peptides — and backs it with a checkable LegitScript certification and HIPAA compliance, but the verdict docks it hard because every line is compounded, not FDA-approved, and the pricing turns opaque the moment you look past the headline GLP-1 tiers.

  • Semaglutide$49/mo
  • Tirzepatide$99/mo
Visit Telos Rx

Assume we may earn a commission, at no cost to you. Partners we work with carry a small, fixed edge in where they are listed; the scores themselves are not adjusted.

Semaglutide
$49/mo (microdosed, annual)
Tirzepatide
$99/mo (annual)
Coverage
Not publicly listed
Brand-name
Compounded only

The scorecard

Telos Rx scored on our six published factors. See the methodology.

Real-world results83/100
Price honesty82/100
Prescriber access87/100
Formulary choice92/100
Cancellation fairness83/100
Member support84/100

What we like

  • Unusually deep published menu — compounded semaglutide and tirzepatide alongside PT-141, intranasal NAD+, and recovery peptides (sermorelin, ipamorelin, CJC-1295, BPC-157)
  • Needle-free and oral routes, including oral and microdosed tirzepatide, for the needle-averse
  • LegitScript-certified and HIPAA-compliant, with US-based providers and pharmacies, plus HSA/FSA and free 48-hour shipping
  • Low published GLP-1 entry — from $49/mo microdosed and $99/mo tirzepatide on annual plans

The caveats

  • Everything is compounded, not FDA-approved — including the peptides, several of which are research-grade with limited human evidence
  • Pricing turns opaque outside the headline GLP-1 tiers, and the cheapest rates require a long annual lock-in (short plans run $145/$199/$399 in the first month)
  • No named clinicians or leadership, and only a thin body of public reviews
  • States served are not published, so confirm your state is covered before you sign up

The verdict

Best for: Patients who want a single LegitScript-verified operator carrying far more than a GLP-1 — oral and microdosed options, peptides and bioidentical HRT — and will accept compounded-only meds and a long annual lock-in in exchange for the lowest published prices.

Ranked #26 of 548 providers we have reviewed — for comparison, read our CoreAge Rx review, ranked #1. In the ranking it sits between Hims & Hers at #25, 85/100 above and No BS RX at #27, 85/100 below, with the Renlo Health write-up the next one down.

Telos Rx is one of 548 providers in this ranking, which makes the fair next question who sits above it — our shortlist of Telos Rx alternatives answers it in order, with every score shown. If you would rather start from the top of the field, our full board of 548 providers is the place to start if you are still shortlisting. We have also compared it head to head: CoreAge Rx vs Telos Rx goes to CoreAge Rx, 94/100 to 85/100.

Compare with other providers

The closest reviews to Telos Rx by Verdict Score — the realistic shortlist if you are weighing this one up.

Pricing, states and verification reflect Telos Rx's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on Telos Rx's site. Not medical advice; see our disclosure.

← Back to all rankings